Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua D Wallach

Showing results (1-10 of 111) with videos related to

Pageof 12
Sort By:
JAMA Internal Medicine|July 30, 2019
Meta-analysis MetastasisJoshua D Wallach
Chemico-Biological Interactions|March 16, 2020
Consideration of confounding in epidemiologic studies assessing alcohol consumption on the risk of breast cancer: A brief reportLingzhi Chu, Joshua D Wallach
International Journal of Epidemiology|February 6, 2017
Commentary: The challenge of evaluating and improving evidence when research lacks reproducibilityJoshua D Wallach, Sanjay Basu
JAMA|July 21, 2018
Off-label Use of Medications-ReplyJoshua D Wallach, Joseph S Ross
Journal of the American College of Cardiology|March 5, 2025
Long-Term Outcomes of Transcatheter vs Surgical Aortic Valve Replacement for Lower-Risk Patients: Are We There Yet?Joshua D Wallach, David J Cohen
Journal of the American College of Cardiology|February 12, 2025
Preprints: A Revolution in Cardiovascular ScienceHarlan M Krumholz, Joshua D Wallach
Annals of Internal Medicine|May 7, 2019
Not Reporting Results of a Clinical Trial Is Academic MisconductJoshua D Wallach, Harlan M Krumholz
JAMA|February 28, 2018
Gabapentin Approvals, Off-Label Use, and Lessons for Postmarketing Evaluation EffortsJoshua D Wallach, Joseph S Ross
Clinical Trials (London, England)|June 7, 2018
The US Food and Drug Administration's expedited approval programs: Evidentiary standards, regulatory trade-offs, and potential improvementsJoshua D Wallach, Joseph S Ross, Huseyin Naci
BMJ (Clinical Research Ed.)|May 16, 2022
Generating evidence during a pandemic: what's reliable?Joshua D Wallach, Osman Moneer, Joseph S Ross
Pageof 12

Showing results (1-10 of 111) with videos related to

Sort By:
Pageof 12
JAMA Internal Medicine|July 30, 2019
Meta-analysis MetastasisJoshua D Wallach
Chemico-Biological Interactions|March 16, 2020
Consideration of confounding in epidemiologic studies assessing alcohol consumption on the risk of breast cancer: A brief reportLingzhi Chu, Joshua D Wallach
International Journal of Epidemiology|February 6, 2017
Commentary: The challenge of evaluating and improving evidence when research lacks reproducibilityJoshua D Wallach, Sanjay Basu
JAMA|July 21, 2018
Off-label Use of Medications-ReplyJoshua D Wallach, Joseph S Ross
Journal of the American College of Cardiology|March 5, 2025
Long-Term Outcomes of Transcatheter vs Surgical Aortic Valve Replacement for Lower-Risk Patients: Are We There Yet?Joshua D Wallach, David J Cohen
Journal of the American College of Cardiology|February 12, 2025
Preprints: A Revolution in Cardiovascular ScienceHarlan M Krumholz, Joshua D Wallach
Annals of Internal Medicine|May 7, 2019
Not Reporting Results of a Clinical Trial Is Academic MisconductJoshua D Wallach, Harlan M Krumholz
JAMA|February 28, 2018
Gabapentin Approvals, Off-Label Use, and Lessons for Postmarketing Evaluation EffortsJoshua D Wallach, Joseph S Ross
Clinical Trials (London, England)|June 7, 2018
The US Food and Drug Administration's expedited approval programs: Evidentiary standards, regulatory trade-offs, and potential improvementsJoshua D Wallach, Joseph S Ross, Huseyin Naci
BMJ (Clinical Research Ed.)|May 16, 2022
Generating evidence during a pandemic: what's reliable?Joshua D Wallach, Osman Moneer, Joseph S Ross
Pageof 12